These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26917467)

  • 1. [Validation of a questionnaire assessing patients' adherence and skill level of management for oral capecitabine treatment].
    Baudot A; Oriol M; Tinquaut F; Moine V; Moriceau G; Muron T; Pacaut C; Collard O; Jacquin JP; Saban-Roche L; Bosacki C; Regnier-Denois V; Chauvin F; Bourmaud A
    Bull Cancer; 2016 Mar; 103(3):241-51. PubMed ID: 26917467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to oral anticancer chemotherapy: What influences patients' over or non-adherence? Analysis of the OCTO study through quantitative-qualitative methods.
    Bourmaud A; Henin E; Tinquaut F; Regnier V; Hamant C; Colomban O; You B; Ranchon F; Guitton J; Girard P; Freyer G; Tod M; Rioufol C; Trillet-Lenoir V; Chauvin F
    BMC Res Notes; 2015 Jul; 8():291. PubMed ID: 26142140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over-adherence to capecitabine: a potential safety issue in breast and colorectal cancer patients.
    Le Saux O; Bourmaud A; Rioufol C; Colomban O; Guitton J; Schwiertz V; Regnier V; You B; Ranchon F; Maraval-Gaget R; Girard P; Chauvin F; Freyer G; Tod M; Henin E; Trillet-Lenoir V
    Cancer Chemother Pharmacol; 2018 Aug; 82(2):319-327. PubMed ID: 29948022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on adherence to capecitabine among patients with colorectal cancer and metastatic breast cancer.
    Figueiredo Junior AG; Forones NM
    Arq Gastroenterol; 2014; 51(3):186-91. PubMed ID: 25296077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compliance with adjuvant capecitabine in patients with stage II and III colon cancer: comparison of administrative versus medical record data.
    Amlani A; Kumar A; Ruan JY; Cheung WY
    Cancer Med; 2016 Aug; 5(8):1776-82. PubMed ID: 27228415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Psychometric Testing of the Turkish-Version Oral Chemotherapy Adherence Scale.
    Bagcivan G; Akbayrak N
    J Nurs Res; 2015 Dec; 23(4):243-51. PubMed ID: 26562455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychometric properties of the Osteoporosis-specific Morisky Medication Adherence Scale in postmenopausal women with osteoporosis newly treated with bisphosphonates.
    Reynolds K; Viswanathan HN; O'Malley CD; Muntner P; Harrison TN; Cheetham TC; Hsu JW; Gold DT; Silverman S; Grauer A; Morisky DE
    Ann Pharmacother; 2012 May; 46(5):659-70. PubMed ID: 22510666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and psychometric evaluation of a novel tool for assessing patient perception and preference for haemophilia treatment (HaemoPREF).
    Teal S; Brohan E; Hettema Y; Humphrey L; Willgoss T; Hudgens S; Westfeld M; Cappelleri JC
    Haemophilia; 2014 Sep; 20(5):666-73. PubMed ID: 24720617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and psychometric evaluation of the Treatment Adherence Questionnaire for Patients with Hypertension.
    Ma C; Chen S; You L; Luo Z; Xing C
    J Adv Nurs; 2012 Jun; 68(6):1402-13. PubMed ID: 21954893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence and safety study in patients on treatment with capecitabine.
    Fernández-Ribeiro F; Olivera-Fernández R; Crespo-Diz C
    Farm Hosp; 2017 Mar; 41(2):204-221. PubMed ID: 28236798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful Capecitabine Desensitization for a Delayed-Type Hypersensitivity Reaction.
    Demir S; Olgac M; Saglam S; Gelincik A; Colakoglu B; Buyukozturk S
    J Investig Allergol Clin Immunol; 2016; 26(1):66-7. PubMed ID: 27012024
    [No Abstract]   [Full Text] [Related]  

  • 13. [Oral capecitabine as postoperative adjuvant chemotherapy in stage III colon cancer patients].
    Yamaguchi T; Fukuda M; Yasui H; Okazaki S; Kubo K; Tanaka M; Une Y; Setoguchi Y; Hanada K; Moriyama S; Tani M; Murakami T; Okuchi Y; Ogiso S; Hata H; Sakata S; Otani T; Yamato T; Ikai I
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):389-93. PubMed ID: 22421765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and validation of the My Medicines and Me Questionnaire for assessment of the self-reported side effects of psychotropic medication.
    Ashoorian DM; Davidson RM; Rock DJ; Dragovic M; Clifford RM
    Int Clin Psychopharmacol; 2015 Jul; 30(4):224-9. PubMed ID: 25852030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence with oral oncologic treatment in cancer patients: interest of an adherence score of all dosing errors.
    Thivat E; Van Praagh I; Belliere A; Mouret-Reynier MA; Kwiatkowski F; Durando X; Mahammedi H; Dillies AF; Chollet P; Chevrier R
    Oncology; 2013; 84(2):67-74. PubMed ID: 23128040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing Medication Adherence Barriers to Short-Term Oral Antibiotic Treatment in Primary Care-Development and Validation of a Self-Report Questionnaire (BIOTICA).
    Haag M; Hersberger KE; Arnet I
    Int J Environ Res Public Health; 2021 Jul; 18(15):. PubMed ID: 34360062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence with oral chemotherapy: results from a qualitative study of the behaviour and representations of patients and oncologists.
    Regnier Denois V; Poirson J; Nourissat A; Jacquin JP; Guastalla JP; Chauvin F
    Eur J Cancer Care (Engl); 2011 Jul; 20(4):520-7. PubMed ID: 20649809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing adherence to oral chemotherapy using different measurement methods: Lessons learned from capecitabine.
    Walter T; Wang L; Chuk K; Ng P; Tannock IF; Krzyzanowska MK
    J Oncol Pharm Pract; 2014 Aug; 20(4):249-56. PubMed ID: 24022406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a social inclusion index to capture subjective and objective life domains (Phase II): psychometric development study.
    Huxley P; Evans S; Madge S; Webber M; Burchardt T; McDaid D; Knapp M
    Health Technol Assess; 2012; 16(1):iii-vii, ix-xii, -1-241. PubMed ID: 22260923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapisal Versus Urea Cream as Prophylaxis for Capecitabine-Associated Hand-Foot Syndrome: A Randomized Phase III Trial of the AIO Quality of Life Working Group.
    Hofheinz RD; Gencer D; Schulz H; Stahl M; Hegewisch-Becker S; Loeffler LM; Kronawitter U; Bolz G; Potenberg J; Tauchert F; Al-Batran SE; Schneeweiss A
    J Clin Oncol; 2015 Aug; 33(22):2444-9. PubMed ID: 26124485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.